Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section
Age: 18+
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: Laval University
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate the effectiveness of two doses of carbetocin (50 mcg vs 100 mcg) in preventing uterine atony during elective cesarean section.
Research Team
JB
Julie Bédard
Principal Investigator
Laval University
Eligibility Criteria
Inclusion Criteria
≥ 18 years old
≥ 37-week pregnancy
singleton pregnancy
See 2 more
Treatment Details
Interventions
- Carbetocin (Oxytocic Agent)
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Carbetocin 50 mcgExperimental Treatment1 Intervention
Group II: Carbetocin 100 mcgActive Control1 Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laval University
Lead Sponsor
Trials
439
Recruited
178,000+